TY - JOUR
T1 - Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas
AU - Huber, H.
AU - Eggert, A.
AU - Janss, A. J.
AU - Wiewrodt, R.
AU - Zhao, H.
AU - Sutton, L. N.
AU - Rorke, L. B.
AU - Phillips, P. C.
AU - Grotzer, M. A.
N1 - Funding Information:
This work was supported by the National Institutes of Health (grant PO1-NS34514) and the Jeffrey Miller Neuro-Oncology Research Fund.
PY - 2001
Y1 - 2001
N2 - Primitive neuroectodermal brain tumours (PNET) including medulloblastomas (PNET/MB) are the most common malignant brain tumours of childhood. Similar to many other brain tumours, PNET/MB often show marked neovascularisation. To determine which angiogenic factors contribute to PNET/MB angiogenesis, we examined the expression of eight angiogenic factors (vascular endothelial growth factors (VEGF, VEGF-B, VEGF-C), basic fibroblast growth factor (bFGF), angiopoetins (Ang-1, Ang-2), transforming growth factor (TGF-α), and platelet-derived endothelial growth factor (PDGF-A)) by semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) in six PNET cell lines and 28 primary PNET/MB. Expression levels of angiogenic factors were compared with microvessel density, TrkC mRNA expression, clinical variables and survival outcomes. Our results indicate that all PNET/MB tested produce a wide range of angiogenic factors that are, individually or together, likely to play a direct role in PNET/MB tumour growth. This suggests that anti-angiogenesis approaches targeting VEGF alone may be insufficient in PNET/MB.
AB - Primitive neuroectodermal brain tumours (PNET) including medulloblastomas (PNET/MB) are the most common malignant brain tumours of childhood. Similar to many other brain tumours, PNET/MB often show marked neovascularisation. To determine which angiogenic factors contribute to PNET/MB angiogenesis, we examined the expression of eight angiogenic factors (vascular endothelial growth factors (VEGF, VEGF-B, VEGF-C), basic fibroblast growth factor (bFGF), angiopoetins (Ang-1, Ang-2), transforming growth factor (TGF-α), and platelet-derived endothelial growth factor (PDGF-A)) by semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) in six PNET cell lines and 28 primary PNET/MB. Expression levels of angiogenic factors were compared with microvessel density, TrkC mRNA expression, clinical variables and survival outcomes. Our results indicate that all PNET/MB tested produce a wide range of angiogenic factors that are, individually or together, likely to play a direct role in PNET/MB tumour growth. This suggests that anti-angiogenesis approaches targeting VEGF alone may be insufficient in PNET/MB.
KW - Angiogenesis
KW - Angiopoetin
KW - Basic fibroblast growth factor
KW - Brain tumour
KW - Medulloblastoma
KW - Platelet-derived endothelial growth factor
KW - Transforming growth factor-α
KW - Vascular endothelial growth factor
UR - http://www.scopus.com/inward/record.url?scp=0034784145&partnerID=8YFLogxK
U2 - 10.1016/S0959-8049(01)00225-8
DO - 10.1016/S0959-8049(01)00225-8
M3 - Article
C2 - 11597385
AN - SCOPUS:0034784145
SN - 0959-8049
VL - 37
SP - 2064
EP - 2072
JO - European Journal of Cancer
JF - European Journal of Cancer
IS - 16
ER -